Healthcare >> CEO Interviews >> January 12, 2004
LARRY C. HEATON II is President and Chief Executive Officer of Curon
Medical, Inc. Mr. Heaton is a 20-year veteran of the healthcare and
medical device industry. Most recently, from 2000 to the present, Mr.
Heaton has been the President, Chief Executive Officer and a Director of
Response Genetics, Inc., an applied genomics startup firm providing
contract research and clinical trial gene expression services to the
pharmaceutical industry. Prior to that, Mr. Heaton spent 18 years with
United States Surgical Corporation, a leading manufacturer of innovative
wound closure products and advanced surgical devices with annual sales
in excess of one billion dollars. His career, which began in 1982,
included leadership positions in various sales, marketing and operations
activities worldwide during which he emphasized the building of strong
customer-focused sales teams. He was very actively involved in multiple
launches of new and minimally invasive technologies to various surgical
specialties, primarily focused on general and colorectal surgeons. From
1998 to 2000, Mr. Heaton served as the President and Chief Operating
Officer of United States Surgical and its various subsidiary companies,
and led the efforts to acquire and integrate several new divisions,
including Davis & Geck, Dexide, General Surgical Innovations (GSI),
Origin and Minimally Invasive Surgical Technologies (MIST). Profile
operations?
Mr. Heaton: Curon Medical was founded in 1997 to develop solutions to
problems of the gastrointestinal tract
